Action 5AR1 JANONE INC.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Communiqués JanOne Inc. BOERSE MUENCHEN

Actions

5AR1

US47089W1045

Marché Fermé - BOERSE MUENCHEN
Autres places de cotation
 21:44:21 05/07/2024 		Varia. 5j. Varia. 1 janv.
1,91 EUR 0,00 % Graphique intraday de JanOne Inc. -9,05 % +283,15 %
17/05 Les fonds négociés en bourse et les contrats à terme sur actions font du sur-place avant la cloche de vendredi, alors que les espoirs d'une baisse des taux d'intérêt en septembre s'amenuisent. MT
16/05 JanOne finalise l'acquisition de la société de technologie financière blockchain -- Les actions chutent après les heures d'ouverture MT

Communiqués

Recherche
Voir les résultats
Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !
Inscription 100% Gratuite
JanOne Appoints Vay Tham as its Chief Revenue Officer and President of its Fintech Subsidiary, ALT5 Sigma
AQ
ALT5 SIGMA, A JANONE COMPANY, ADDS PREPAID VISA®️ CARD INTEGRATION TO ALT5 SETTLEMENT PLATFORM
AQ
JanOne's Subsidiary, Alt5, Reports 91% year over year increase in Transaction Volume to US $289 million for April and May 2024
AQ
ALT5 Sigma, a wholly-owned subsidiary of JanOne, Launches ALT5 Settlement Platform aimed at the untapped $27.3 Billion Global Digital Content Creation Market
PR
JanOne Inc. added to the Russell Microcap® Index
PR
ALT 5 Sigma, a wholly-owned subsidiary of JanOne to Present at the iFX Expo, the World's largest online trading conference and tradeshow
PR
JanOne Closes Acquisition of ALT 5 Sigma Inc., a Leading Next Generation Blockchain Fintech
PR
JanOne to Acquire ALT 5 Sigma Inc., a Leading Next Generation Blockchain Financial Technology Provider
PR
JanOne to Acquire ALT 5 Sigma Inc., a Leading Next Generation Blockchain Financial Technology Provider
PR
JanOne Regains Compliance with Nasdaq's Listing Requirements
PR
JanOne to Present at the Dawson James 8th Annual Investment Conference
PR
JanOne to Present In Person and by Video at H.C. Wainwright's 25th Annual Global Investment Conference
PR
JanOne Earns US Patent for the Use of its Novel Formulation of Low-Dose Naltrexone, Jan123, to Treat Chronic Pain
PR
JanOne Wins 'Best Abstract' Award at the Ohio Society of Interventional Pain Physicians Annual Meeting
AQ
JanOne Wins "Best Abstract" Award at the Ohio Society of Interventional Pain Physicians Annual Meeting
PR
JanOne Technologies Announces Closing of Registered Direct Offering Priced At-The-Market under Nasdaq Rules
PR
JanOne to Present Prior Phase II Data on Diabetic Neuropathy at the Ohio Society of Interventional Pain Physicians Annual Meeting
AQ
JanOne Technologies Announces Registered Direct Offering Priced At-The-Market under Nasdaq Rules
AQ
JanOne Technologies Announces Registered Direct Offering Priced At-The-Market under Nasdaq Rules
PR
JanOne to Present Prior Phase II Data on Diabetic Neuropathy at the Ohio Society of Interventional Pain Physicians Annual Meeting
PR
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action JAN
  4. Action 5AR1
  5. Actualités JanOne Inc.
  6. Communiqués